These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2403715)

  • 1. Shifting patterns of cortical cholinesterases in Alzheimer's disease: implications for treatment, diagnosis, and pathogenesis.
    Mesulam MM; Geula C
    Adv Neurol; 1990; 51():235-40. PubMed ID: 2403715
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
    Volger BW
    Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
    Mesulam MM; Geula C; Morán MA
    Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electron-cytochemical study of acetylcholinesterase in the cerebral cortex in Alzheimer's disease].
    Vostrikov VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(7):1003-6. PubMed ID: 3765981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D; Zou C; Luo C; Tang X; Li Y
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease and the new neuroscience.
    Wortis J
    Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
    Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
    Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the studies of the etiology and treatment of Alzheimer's disease].
    Jarema M
    Wiad Lek; 1988 Jun; 41(11):717-23. PubMed ID: 3070943
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease: a new hope.
    Hasan MK; Mooney D
    W V Med J; 1994 Oct; 90(10):418-9. PubMed ID: 7801627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease.
    Szymański P; Zurek E; Mikiciuk-Olasik E
    Pharmazie; 2006 Apr; 61(4):269-73. PubMed ID: 16649535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on cholinergic enhancement therapy for Alzheimer disease.
    Read SL
    Bull Clin Neurosci; 1987; 52():34-7. PubMed ID: 3334548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing function in Alzheimer's disease: what role for tacrine?
    Smucker WD
    Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G
    Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for Alzheimer's disease.
    Harvey R; Rossor M
    Practitioner; 1995 Jul; 239(1552):440-3. PubMed ID: 7659667
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrine therapy for the dementia of Alzheimer's disease.
    Manning FC
    Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease.
    Gustafson L
    Acta Neurol Scand Suppl; 1993; 149(Rand):39-41. PubMed ID: 8128836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease.
    Marco-Contelles J; León R; de Los Ríos C; Guglietta A; Terencio J; López MG; García AG; Villarroya M
    J Med Chem; 2006 Dec; 49(26):7607-10. PubMed ID: 17181144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.